Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Stereotactic Body Radiotherapy”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableLooking for participantsNCT05916040
What this trial is testing

Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy

Who this might be right for
Rectal Cancer
Universitair Ziekenhuis Brussel 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03141359
What this trial is testing

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

Who this might be right for
Lung Cancer Stage IILung Cancer Stage IIINon Small Cell Lung Cancer
Wake Forest University Health Sciences 61
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Testing effectiveness (Phase 2)Study completedNCT02723331
What this trial is testing

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaPancreas Ductal Adenocarcinoma
Academic Thoracic Oncology Medical Investigators Consortium 48
Very early researchWithdrawnNCT03574220
What this trial is testing

Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03875573
What this trial is testing

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

Who this might be right for
Luminal B
Jules Bordet Institute 147
Early research (Phase 1)Active Not RecruitingNCT02685332
What this trial is testing

Phase I Dose Escalation of Single Fraction Adjuvant Stereotactic Body Partial Breast Irradiation Early Stage Breast CA

Who this might be right for
Early Stage Breast Cancer
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04915508
What this trial is testing

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

Who this might be right for
Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 102
Not applicableLooking for participantsNCT06946238
What this trial is testing

Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F)

Who this might be right for
Breast Cancer
IRCCS San Raffaele 311
Testing effectiveness (Phase 2)Study completedNCT01595321
What this trial is testing

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Not applicableNot Yet RecruitingNCT05411809
What this trial is testing

The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer

Who this might be right for
Stereotactic Body Radiation Therapy
Peking University Third Hospital 180
Testing effectiveness (Phase 2)Study completedNCT02057107
What this trial is testing

SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN

Who this might be right for
Previously-IrradiatedSquamous Cell Carcinoma of the Head and Neck Cancer
Heath Skinner 40
Testing effectiveness (Phase 2)UnknownNCT02461836
What this trial is testing

Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1)

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 513
Not applicableNot Yet RecruitingNCT05602974
What this trial is testing

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

Who this might be right for
Hepatocellular CarcinomaNarrow MarginAdjuvant Stereotactic Body Radiotherapy+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 140
Testing effectiveness (Phase 2)Looking for participantsNCT06313190
What this trial is testing

Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 140
Not applicableLooking for participantsNCT07077239
What this trial is testing

Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

Who this might be right for
Prostate Cancer (CRPC)
Jonsson Comprehensive Cancer Center 200
Not applicableStudy completedNCT02516969
What this trial is testing

Surgery With or Without Adjuvant Stereotactic Body Radiotherapy

Who this might be right for
Head and Neck Cancer
David A. Clump, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT03767582
What this trial is testing

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 46
Not applicableStudy completedNCT04891874
What this trial is testing

Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 76
Not applicableNot Yet RecruitingNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Load More Results